Skip to main content
September 24

September 24, 2025
Munich, Germany

Berenberg and Goldman Sachs 14th German Corporate Conference

September 23

September 23, 2025
London, UK

Bank of America Global Healthcare Conference 2025

September 18

September 18, 2025
Frankfurt, Germany

Barclays 2025 EU MedTech & Life Sciences Investor Trip

September 10

September 10, 2025
New York, USA

Morgan Stanley 23rd Annual Global Healthcare Conference

September 03

September 03, 2025
Boston, USA

Wells Fargo Healthcare Conference

September 03

September 03, 2025
London, UK

Goldman Sachs 22nd Annual Medtech and Healthcare Services Conference

September 02

September 02, 2025
Frankfurt, Germany

BNP Exane Healthcare Bus Tour 2025

August 07

August 07, 2025
London, UK

Roadshow London

Fresenius Digital Technology Polska sp. z o.o., with its registered office in Wrocław (address: pl. Nowy Targ 28, 50-141 Wrocław), entered into the Register of Entrepreneurs of the National Court Register maintained by the District Court for Wrocław-Fabryczna in Wrocław, 6th Commercial Division of the National Court Register under KRS number 0000914913, NIP 8943171759, with a share capital of PLN 135,000.00, is represented by the Management Board acting in accordance with the rules of representation disclosed in the National Court Register. 

We are committed to maintaining the highest standards of ethics and integrity. In accordance with Polish regulations, individuals can confidentially report any suspected violations, unethical behavior or compliance issues through the following channels: 

Email: sygnalisci@fresenius.com 
Group Whistleblowing Channel: Our grievance mechanism | FSE 

All reports are handled with strict confidentiality and in line with applicable data protection laws. Retaliation against whistleblowers is strictly prohibited.

Fresenius has published the Aide Memoire ahead of its Q2 2025 financial reporting. The Aide Memoire is a summary of relevant information that Fresenius has previously communicated previously to the capital market or otherwise made publicly available . The document may prove helpful in assessing Fresenius' financial performance ahead of the publication of quarterly results.

The Q2 2025 Aide Memoire is now available on the Fresenius Investor Relations website. The results of the second quarter and first half of 2025 of Fresenius SE & Co. KGaA will be published on 6 August 2025. The Quiet Period will start on 24 July 2025.
 

Subscribe to